Mehdi Paborji - Rain Enhancement VP Operations

RAIN Stock  USD 2.03  0.19  8.56%   

Insider

Mehdi Paborji is VP Operations of Rain Enhancement Technologies
Age 69
Address 1659 Chinaberry Ct., Naples, FL, United States, 34105
Phone(508) 361-6699
Webhttps://rainwatertech.com

Rain Enhancement Management Efficiency

The company has return on total asset (ROA) of (0.5219) % which means that it has lost $0.5219 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9704) %, meaning that it created substantial loss on money invested by shareholders. Rain Enhancement's management efficiency ratios could be used to measure how well Rain Enhancement manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Rain Enhancement's Return On Capital Employed is very stable compared to the past year. As of the 14th of March 2025, Return On Equity is likely to grow to 0.83, while Return On Tangible Assets are likely to drop (1.00). At this time, Rain Enhancement's Net Tangible Assets are very stable compared to the past year. As of the 14th of March 2025, Intangibles To Total Assets is likely to grow to 0.19, while Total Assets are likely to drop about 565.7 K.
Rain Enhancement Technologies currently holds 611.26 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Rain Enhancement Tec has a current ratio of 7.06, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Rain Enhancement's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 11 records

INSIDER Age

Avani KanubaddiEnveric Biosciences
51
RPh PharmDElevation Oncology
40
Peter FacchiniEnveric Biosciences
61
Ryan BloomerElevation Oncology
N/A
David DornanElevation Oncology
47
Joseph FerraElevation Oncology
50
MBA IVEnveric Biosciences
68
Ibrahim MDEnveric Biosciences
55
Joseph TuckerEnveric Biosciences
56
Brian SullivanElevation Oncology
N/A
Valerie MDElevation Oncology
47
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Rain Therapeutics Inc. was incorporated in 2017 and is headquartered in Newark, California. Rain Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 44 people. Rain Enhancement Technologies (RAIN) is traded on NASDAQ Exchange in USA. It is located in 1659 Chinaberry Ct., Naples, FL, United States, 34105 and employs 14 people. Rain Enhancement is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Rain Enhancement Tec Leadership Team

Elected by the shareholders, the Rain Enhancement's board of directors comprises two types of representatives: Rain Enhancement inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rain. The board's role is to monitor Rain Enhancement's management team and ensure that shareholders' interests are well served. Rain Enhancement's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rain Enhancement's outside directors are responsible for providing unbiased perspectives on the board's policies.
Oanh Truong, Interim Officer
Lucio Tozzi, VP Operations
Nora MD, MD Development
Nelson Cabatuan, Sr Admin
Avanish MBA, CEO CoFounder
Mehdi Paborji, VP Operations
Theresa MS, Director Operations
Erik Atkisson, General Officer
Charmi Turner, Vice Culture
Josephine Bruce, Principal officer
Richard Bryce, Ex Officer
Vijaya Tirunagaru, Senior Research
Buenaflor MPH, Head VP
Randall Seidl, CEO Director

Rain Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Rain Enhancement a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
When determining whether Rain Enhancement Tec is a strong investment it is important to analyze Rain Enhancement's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Rain Enhancement's future performance. For an informed investment choice regarding Rain Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rain Enhancement Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rain Enhancement. If investors know Rain will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rain Enhancement listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.50)
Return On Assets
(0.52)
Return On Equity
(0.97)
The market value of Rain Enhancement Tec is measured differently than its book value, which is the value of Rain that is recorded on the company's balance sheet. Investors also form their own opinion of Rain Enhancement's value that differs from its market value or its book value, called intrinsic value, which is Rain Enhancement's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rain Enhancement's market value can be influenced by many factors that don't directly affect Rain Enhancement's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rain Enhancement's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rain Enhancement is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rain Enhancement's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.